Back to MORGAN STANLEY MORGAN STANLEY

INBXINBX
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in INHIBRX BIOSCIENCES INC

MORGAN STANLEY holds 1.3M shares of INBX (INHIBRX BIOSCIENCES INC), worth $84.9M as of 2026-Q1. The position was increased (+8.2% shares). INBX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$84.9M

Current Shares

1.3M

Total Value Change

+$81.6M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.3M
+8.2%
$84.9M0.0%$74.33
32
2025-Q4
Increased
1.2M
+163.7%
$92.3M0.0%$77.98
48
2025-Q3
Increased
442,856
+1492.5%
$14.9M0.0%$32.31
45
2025-Q2
Decreased
27,808
-24.6%
$396,8210.0%$14.43
0
2025-Q1
Decreased
36,900
-7.1%
$516,2300.0%$14.12
0
2024-Q4
Decreased
39,715
-83.4%
$611,6120.0%$15.14
0
2024-Q3
Increased
239,240
+1.4%
$3.7M0.0%$15.52
27
2024-Q2
New
235,916
-
$3.3M0.0%$14.17
37

Other major holders of INBX: VIKING GLOBAL INVESTORS LP, HighTower Advisors, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used